Domain interactions within Fzo1 oligomers are essential for mitochondrial fusion by Griffin, Erik E. & Chan, David C.
Domain Interactions within Fzo1 Oligomers Are Essential
for Mitochondrial Fusion*
Received for publication, February 27, 2006, and in revised form, April 12, 2006 Published, JBC Papers in Press, April 19, 2006, DOI 10.1074/jbc.M601847200
Erik E. Griffin and David C. Chan1
From the Division of Biology, California Institute of Technology, Pasadena, California 91125
Mitofusins are conserved GTPases essential for the fusion of
mitochondria. Thesemitochondrial outermembrane proteins con-
tain a GTPase domain and two or three regions with hydrophobic
heptad repeats, but little is known about how these domains inter-
act to mediate mitochondrial fusion. To address this issue, we have
analyzed the yeast mitofusin Fzo1p and find thatmutation of any of
the three heptad repeat regions (HRN,HR1, andHR2) leads to a null
allele. Specific pairs of null alleles show robust complementation,
indicating that functional domains need not exist on the samemol-
ecule. Biochemical analysis indicates that this complementation is
due to Fzo1p oligomerization mediated by multiple domain inter-
actions. Moreover, we find that two non-overlapping protein frag-
ments, one consisting of HRN/GTPase and the other consisting of
HR1/HR2, can form a complex that reconstitutes Fzo1p fusion
activity. Each of the null alleles disrupts the interaction of these two
fragments, suggesting that we have identified a key interaction
involving the GTPase domain and heptad repeats essential for
fusion.
The balance between fusion and fission maintains mitochondria as a
dynamic tubular reticulum. In the absence of fusion, ongoing fission
results in complete fragmentation of the mitochondrial network. Frag-
mentation leads to a loss of mtDNA and respiratory incompetence in
yeast (1, 2) and accumulation of poorly functional mitochondria in
mammals (3). Mice deficient for mitochondrial fusion die during mid
gestation (4), and mutations in the mitochondrial fusion genes Mfn2
andOPA1 cause the neurodegenerative diseases Charcot-Marie-Tooth
disease type 2A and dominant optic atrophy, respectively (5–9). Im-
portantly, the mitochondrial fusion machinery is dedicated solely to
mitochondrial fusion and does not include SNARE2 proteins or NSF
(N-ethylmaleimide-sensitive protein), which mediate most other intra-
cellular membrane fusion events. Thus, mitochondrial fusion likely
involves a unique mechanism.
There are three essential components of the fusion pathway in yeast.
The yeast mitofusin Fzo1p is a 98-kDa transmembrane GTPase uni-
formly distributed in themitochondria outer membrane (1, 2). Both the
N- and C-terminal portions of Fzo1p are oriented toward the cytosol, in
position to mediate important steps during fusion (1, 2). Mgm1p is a
dynamin-related protein in the mitochondrial intermembrane space
(10–12). It remains unclear ifMgm1ppossesses themembrane severing
activity of other dynamin family members, and if so, how this activity
relates to its requirement for fusion. The third component of the fusion
pathway is Ugo1p, a 58-kDa protein that spans the outer membrane
once and interacts with both Fzo1p and Mgm1p (10, 12–14). In this
capacity, Ugo1p may anchor a fusion complex that coordinates the
mitochondrial outer and inner membranes during fusion.
Fzo1p is the best candidate to directly mediate fusion of the mito-
chondrial outer membrane. UnlikeMgm1p, it is positioned in the outer
membrane and unlikeUgo1p its requisite role is conserved fromyeast to
mammals. In addition, Fzo1p has three hydrophobic heptad repeat (HR)
regions that are predicted to form coiled-coils. Heptad repeat regions
are directly involved in SNARE and Class I viral membrane fusion. In
both cases, membrane fusion is driven when a trans complex that spans
both membranes undergoes a structural transition to a highly stable
fusogenic conformation. These fusogenic structures use coiled-coil-like
helical bundles to position the twomembranes in close apposition, lead-
ing to fusion (15–18).
Given these similarities, it is likely that the heptad repeat regions form
interactions critical for mitochondrial fusion. Indeed, the mammalian
mitofusins Mfn1 and Mfn2 form homotypic and heterotypic com-
plexes, and several intermolecular interactions have been identified.
Mfn1 HR2 is known to form a trans anti-parallel, dimeric coiled-coil
that tethers mitochondria together (19). There is also evidence that
Mfn1 HR1 andHR2 interact with each other (20). Moreover, Fzo/mito-
fusins have similarity to dynamins, a family of large membrane-associ-
ated GTPases characterized by oligomerization-stimulated GTP
hydrolysis and multiple inter- and intramolecular interactions (21). It
has not been established if Fzo1p forms similar intermolecular interac-
tions that contribute to mitochondrial fusion.
In this study, we show that Fzo1p functions as an oligomer during
mitochondrial fusion. We demonstrate that each of the Fzo1p heptad
repeats is essential and that the GTPase domains and heptad repeats
from different Fzo1pmolecules within an oligomer function together to
mediate fusion. Finally, we define a novel interaction between theHRN/
GTPase and HR1/HR2 regions of Fzo1p that is essential for mitochon-
drial fusion.
EXPERIMENTAL PROCEDURES
Media and Yeast Genetic Techniques—Standard genetic tech-
niques and media were used. SD and YP media supplemented with
either 2% dextrose (YPD) or 3% glycerol (YPG) were prepared as
described previously (22).
DCY538 (MATa, ura3–52, his3200, leu21, trp163, lys2202,
fzo1::HIS3, leu2:: GPD-mitoGFP-LEU2, pRS416-FZO1) was derived
from JSY2287 (kindly provided by J. Shaw) (1) by integration of
BstEII-linearized EG686 (pRS405 plus mito-GFP) into the leu21
locus. DCY328 (MAT, ura3–52, his3200, leu21, trp163,
fzo1::HIS3, rho0) was derived from JSY2793 (1) by selecting for the
loss of pRS414-fzo1–1.
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Because the loss of mtDNA in fzo1 yeast is a non-revertible pheno-
type, a plasmid-shuffle strategy was used to generate yeast strains for
structure-function and intragenic allelic complementation analyses.
Briefly, DCY538, a rho yeast strain containing a chromosomal deletion
of FZO1 covered by an FZO1-expressing plasmid (pRS416-FZO1), was
transformed with a plasmid encoding an FZO1 under TRP1 selection
(structure-function experiments) or two FZO1 plasmids under TRP1
and LYS2 selection (intragenic complementation experiments). The
transformation plates were replica-plated, and the pRS416-FZO1 plas-
mid was removed by counterselection with 5-fluoroorotic acid. The
resulting yeast colonies were replica-plated onto YPD and YPG plates.
The glycerol growth phenotype was reproducibly evident after 3 days of
growth. In the intragenic complementation experiments, for example,
all colonies showed growth on YPG plates when a pair of null alleles
were complemented. For quantitative serial dilution andmorphological
analysis, representative colonies were isolated and re-analyzed. The
possibility of recombination events was excluded by the presence of
many non-complementing pairs of alleles (for example, fzo1(V172P)
and fzo1(L819P)), the robust complementation between non-overlap-
ping fragments (Fzo1p-HRN/GTPase plus Fzo1p-HR1/HR2), and the
reproducibility of the glycerol growth phenotype among all colonies at
the replica plating stage. In addition, in the complementation experi-
ment involving Fzo1p-HRN/GTPase and Fzo1p-HR1/HR2, Western
blot analysis confirmed the expression of the proper fragments.
Mitochondrial Morphology and Glycerol Growth Analysis—Yeast
strains expressing the indicated FZO1 constructs were generated
through a plasmid shuffle strategy and grown at 30 °C in appropriate SD
medium overnight. Cultures were diluted 1:20 in fresh YPD medium
and counted live during logarithmic growth. For glycerol growth assays,
cultures grown overnight in SDmediumwere pelleted, resuspended at a
density of 1 A600 unit/ml and diluted 1:5 six times in YP. 3 l of the
dilutions was spotted to plates and grown for 2 days (YPD) or 4 days
(YPG) at 30 °C.
Plasmid Construction—pRS414-9XMyc-FZO1 (EG36) was con-
structed as follows. The FZO1 terminator was amplified from genomic
DNAusing the oligonucleotides Eg5 (CTCTATACGAAGGAACCGT-
GGCTC) and Eg6 (GCAGAATTCTTGTTGTCTTTTAAATGGAG)
and cloned as a ClaI/EcoRI fragment. The FZO1 coding sequence was
cloned as a SalI and ClaI fragment using the FZO1 forward primer Eg3
(ACCATGGTCGACTCTGAAGGAAAACAACAATTC) to engineer
a SalI restriction site following the initiatorATG.The FZO1 5-untrans-
lated regionwas amplified using the primers Eg1 (GCAGGTACCAAG-
GAGTTTGTGTCGTTTTTCAC) and Eg2 (CAGAGTCGACCATG-
GTCGTTAAATGAGCCTACCGTTTTGCC) and cloned as a KpnI/
SalI fragment. These fragments were all subcloned into pRS414
(Stratagene) to yield pRS414-FZO1 (EG32). Next, a 9XMyc cassette was
cloned into the SalI site to yield pRS414-9XMyc-FZO1 (EG36). The
entire 9XMyc-FZO1 cassette was moved as a KpnI (blunted)/EcoRI
fragment into SmaI and EcoRI sites of pRS317 to generate pRS317-
9XMyc-FZO1 (EG197). The 9XMyc cassette in EG36was replaced with
a 6XHA cassette (XhoI/SalI fragment) to generate pRS414-6XHA-
FZO1 (EG594). The entire 6XHA-FZO1 fragmentwasmoved as aKpnI/
EcoRI fragment into pRS416, resulting in pRS416-6XHA-FZO1
(EG600).
pRS416plus 6XHA-FZO1-HR1/HR2 (residues416–855)wasgenerated
using the primer Eg253 (GCAGTCGACCATTATCATAATGAAA-
ATG). pRS414-9XMyc-FZO1-HRN/GTPase-(1–415) was generated with
the primer Eg226 (GCAATCGATTGGCAATTCATCTCCGTT). Muta-
tions were initially generated in the pRS414-9XMyc-FZO1 vector with the
QuikChange site-directed mutagenesis kit (Stratagene) or by subcloning
PCR products containing the indicated mutations. Primer sequences are
available upon request.
Mating Assay—The indicated yeast strains were grown overnight in
the appropriate SDmedium, mixed by gently centrifuging together and
incubated in YPD at 30 °C for 5 h. The cells were then fixed for 10 min
with 3.7% formaldehyde and washed four times with 1ml of phosphate-
buffered saline. Large budded zygotes were scored for the complete
overlap of the mito-GFP and mito-DsRed signals. Plasmids were
expressed in DCY1440 (MAT, his3200,met150, trp163, ura30,
dnm1::HIS5, fzo1::KANMX6, lue2::GPD mito-DsRed-LEU2) and
DCY1553 (MATa, his3200, met150, trp163, ura30, dnm1::HIS5,
fzo1::KANMX6, leu2::GPD mito-GFP-LEU2). DCY1451 (MAT,
his3200, met150, trp163, ura30, dnm1::HIS5, leu2::GPD mito-
DsRed-LEU2) and DCY2312 (MATa, his3-, met150, ura30,
dnm1::kanMX6, leu2::GPD mito-GFP-LEU2) were used for the two
FZO1 dnm1 strains.
Immunoprecipitations—9XMyc- and 6XHA-tagged Fzo1p con-
structs were expressed in a rho0 fzo1 strain (EG328). The use of a rho0
strain eliminated differences in mtDNA levels supported by functional
and null alleles of FZO1. Overnight cultures were grown in the appro-
priate SDmedium, diluted into YPD and harvested at A600 1.5. Then,
50 A600 units of cells was disrupted by glass bead lysis (40 s with a
vortex mixer, four times) in 500 l of lysis buffer (50 mM Tris, pH 7.4,
150 mM NaCl, 0.5 mM EDTA, 0.2% Triton X-100) supplemented with
fungal protease inhibitors (Sigma-Aldrich). Lysateswere cleared by cen-
trifugation at 5,000 rpm for 5 min and 14,000 rpm for 15 min at 4 °C. A
total lysate sample was taken, and 400 l of the remaining lysate was
incubated with to 20 l (bead volume) of 9E10-conjugated protein
A-Sepharose beads (Sigma-Aldrich) for 90 min at 4 °C. The beads were
then washed four times with 1 ml of lysis buffer and eluted in SDS gel
loading buffer for 5 min at 95 °C. Western blot analysis was performed
with 9E10 hybridoma supernatant (anti-Myc) or 12CA5 ascites fluid
(anti-HA).
Immunofluorescence—The indicated 9XMyc-Fzo1p constructs were
introduced in DCY538 by a plasmid shuffle. YPD cultures at1.5 A600
were fixed for 10 min with 3.7% formaldehyde. The cells were washed
four times with water and spheroplasted with Zymolyase 100T (ICN).
Spheroplasts were permeabilized for 10 min in blocking buffer (phos-
phate-buffered saline containing 1% bovine serum albumin and 1%
Tween 20) and incubated for 1 h with 9E10 hybridoma diluted 1:1 in
blocking buffer. After four 5-min washes with blocking buffer, the
cells were incubated with a Cy3-conjugated anti-mouse secondary
antibody for 1 h. After four 5-min washes, Gel Mount (BioMedia)
was added to preserve fluorescence. All incubations were performed
at room temperature.
Imaging—Images were acquired on a Axiovert 200M microscope
(Carl Zeiss MicroImaging, Inc.) equipped with a 100 Plan-Apochro-
mat, numerical aperture 1.4, oil-immersion objective and controlled by
Axiovision 4.2 software. Z-stacks were collected at 100- to 200-m
intervals with an ORCA-ER camera (Hamamatsu) at room tempera-
ture. Iterative deconvolutions andmaximum intensity projections were
performed using Axiovision 4.2. Fluorescent images were overlaid with
differential interference contrast images set at 50% opacity (Fig. 1) using
Adobe Photoshop CS.
RESULTS
Identification of Essential Fzo1p Domains—Fzo1p has a bipartite
transmembrane domain that resides in the mitochondrial outer mem-
brane and divides the protein into N- and C-terminal regions, both of
which face toward the cytosol (Fig. 1A) (1, 2, 23). TheN-terminal region
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contains a GTPase domain that is required for fusion (1). Fzo1p also
contains three domains with hydrophobic heptad repeats. Like other
mitofusins, including the mammalian Mfn1 and Mfn2, Fzo1p contains
the hydrophobic heptad repeat regions HR1 and HR2, which flank the
transmembrane domain (Fig. 1A). However, Fzo1p also contains an
additional heptad repeat region near theN terminus that we termHRN.
Because the role of these heptad repeats in Fzo1p-mediated mitochon-
drial fusion has not previously been assessed, we performed a structure-
function analysis of Fzo1p HRN, HR1, and HR2. Our analysis made use
of the fact that loss of Fzo1p function causes complete fragmentation of
FIGURE 1. Identification of critical regions of Fzo1p. A, schematic of Fzo1p, including HRN (residues 91–190), the GTPase domain (residues 194–373), HR1 (residues 484–547), the
bipartite transmembrane (TM) domain (residues 717–750), andHR2 (residues 769–831). Thepointmutations analyzedare indicatedbelow.B, a serial dilutiongrowthassay to analyze
fzo1 yeast expressing the indicated alleles of FZO1. Growth on rich dextrose (YPD) and glycerol (YPG) plates are shown. These strains were generated through a plasmid-shuffle
strategy in which pRS416-FZO1 is replaced by a pRS414-9XMyc-FZO1 plasmid containing the indicatedmutations. Null alleles analyzed further in this report are indicated in bold. C,
summary of mitochondrial morphologies in yeast expressing the indicated fzo1 mutant. Examples of the morphology classes are shown in the images above. 200 live cells were
analyzed during log phase growth in minimal selective media; percentages are indicated.
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the mitochondrial reticulum due to ongoing mitochondrial fission (1,
24). In addition, because mitochondrial fragmentation leads to a sec-
ondary loss of mitochondrial DNA, fusion mutants can grow on the
fermentable carbon source dextrose but not the non-fermentable car-
bon source glycerol (1). Thus, we assessed the function of Fzo1p
mutants bymonitoringmitochondrial morphology and growth on glyc-
erol plates.
HR1 is 64 residues long (residues 484–547 as predicted by COILS) and
lies between the GTPase domain and transmembrane domain (Fig. 1A)
(25). We substituted proline residues along HR1 to disrupt the predicted
coiled-coil structure (Y490P, L518P, M525P, and K538P). Proline residues
impose a kink in the protein backbone and are often incompatible with a
helical fold, althoughsometimes suchsubstitutionscanbe toleratedby local
distortions in backbone geometry. The mutant fzo1(M525P) retained sig-
nificant function,whereas fzo1(Y490P), fzo1(L518P), and fzo1(K538P)were
strong loss-of-function alleles, incapable of supporting growth on glycerol
plates or rescuing fragmentation of the mitochondrial network (Fig. 1, B
and C). In addition, we substituted alanine for leucine at two a and d posi-
tions, Leu-501 and Leu-504. Bulky hydrophobic residues at the a and d
positionsof theheptad repeat (abcdefg) formastablehydrophobic interface
between the interacting helices of a coiled coil; their substitution by the
smaller residue alanine is predicted to destabilize this interface. Individu-
ally, fzo1(L501A) and fzo1(L504A) behaved asmild loss-of-function alleles.
However, the double mutant fzo1(L501A,L504A) behaved as a null allele,
showing no growth on glycerol and completely fragmentedmitochondrial
morphology (Fig. 1, B and C). Taken together, our mutagenesis of HR1
generated an allelic series anddemonstrated thatHR1 is essential for Fzo1p
function.
FIGURE 2. Allelic complementation between null alleles of FZO1. A, schematic of the null mutations used for allelic complementation analysis. Asterisks are used to indicate the
mutations in HRN (V172P), HR1 (L501A,L504A), andHR2 (L819P) in B. B, serial dilution assay for growth on dextrose and glycerol plates. The assays were performed as in Fig. 1, except
that the null FZO1 alleles were co-expressed from pRS414-9XMyc-FZO1 and pRS317-9XMyc-FZO1 plasmids. A schematic of the different co-expressed alleles is indicated on the left.
C, summary of mitochondrial morphologies in yeast expressing the indicated alleles. 200 live cells were counted for each strain; percentages are indicated.
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In mammalian Mfn1, HR2 forms an anti-parallel dimer that tethers
mitochondria together at an early step in fusion (19). Proline substitu-
tions in Mfn1 HR2 prevent mitochondrial tethering and block mito-
chondrial fusion (19). Proline substitutions at residues Leu-776, Leu-
794, and Leu-802 of Fzo1pHR2 (residues 764–826) were tolerated with
only modest effects on FZO1 function (Fig. 1, B and C). However, pro-
line substitutions at positions Tyr-769, Leu-773, and Leu-819 in HR2
caused a complete loss of function and resulted in no growth on glycerol
plates and mitochondrial fragmentation (Fig. 1, B and C). Thus, like
Mfn1 HR2, Fzo1p HR2 is essential for mitochondrial fusion.
HRN (residues 91–190) is also required for FZO1 function. Initial
experiments showed that N-terminal truncations that spared HRN had
little effect on FZO1 activity, whereas truncations that deleted portions
of HRN behaved as null alleles.3 In addition, fzo1(L98P) had only slight
loss of function, whereas fzo1(V172P) behaved as a null allele (Fig. 1, B
and C). Taken together, these results indicate that like HR1 and HR2,
HRN is essential for Fzo1p activity.
Wemade several further observations in our structure-function anal-
ysis. First, consistent with previous reports, mutations in the GTPase
domain of FZO1 (fzo1(K200A), fzo1(S201N), and fzo1(T221A)) all
caused complete fragmentation of themitochondrial reticulum (1). Sec-
ond, in several of the null mutants (including fzo1(V172P), fzo1(T221A),
fzo1(Y490P), and fzo1(L518P)) the mitochondrial fragments frequently
formed loose aggregates (Fig. 1C). The basis of this aggregation is
unclear, but may reflect the trapping of tethered intermediates. Finally,
the charged residues present in the bipartite transmembrane domain
are not essential for fusion. Fzo1p has three lysines (Lys-727, Lys-735,
and Lys-736) in the region of the transmembrane domain thought to
form a U-turn in the intermembrane space. The triple mutant
fzo1(K727A,K735A,K736A) was highly functional (Fig. 1, B and C).
Thus, although the loop residing in the intermembrane space is impor-
tant for Fzo1p function (23), its charged nature is not essential.
Intragenic Complementation between FZO1 Null Alleles—Mamma-
lianmitofusins have been shown to formhigher order complexes (4, 26),
and Fzo1p has been shown to be present in a high molecular weight
complex in yeast (2). In unusual cases, proteins that self-assemble can
show intragenic complementation, a genetic phenomenon that results
from formation of a functional complex from individually nonfunc-
tional subunits (27). To test whether yeast Fzo1p could exhibit intra-
genic complementation, we used a plasmid-shuffle strategy to construct
fzo1 strains co-expressing two null fzo1 alleles. The function of the
co-expressed null alleles was evaluated by growth on glycerol plates and
mitochondrial morphology. Based on our results above, we used
fzo1(V172P), fzo1(L501A, L504A), and fzo1(L819P) as representative
null alleles with mutations in HRN, HR1, and HR2, respectively (Fig.
2A). These mutants were tested along with the three GTPase mutants.
With these 6mutants, we constructed 15 pairwise combinations, and
intragenic complementation was reproducibly observed in 6 cases
(Table 1 and Fig. 2). Co-expression of either of two GTPase mutants
with a heptad repeat (HR) mutant restored Fzo1p function. In repeated
trials, the GTPase mutants fzo1(K200A) or fzo1(T221A) showed strong
complementation with either fzo1(V172P), fzo1(L501A, L504A), or
fzo1(L819P), resulting in tubular mitochondrial morphology that corre-
sponded with a restored ability to grow on glycerol plates (Fig. 2, B and
C). Thus, Fzo1p activity can occur when the function of theGTPase and
heptad repeat regions reside on different Fzo1p molecules. These
complementation data also indicate that the null mutations do not have
global effects on Fzo1p structure.
In contrast, many pairs of alleles failed to complement. The GTPase
mutant fzo1(S201N) did not complement any of the heptad repeat
mutants (see next section). No complementationwas observedwhen an
HR1 mutant (fzo1(L501A,L504A)) was co-expressed with an HR2
mutant (fzo1(L819P)) or anHRNmutant (fzo1(V172P)) (Fig. 2,B andC).
In addition, when an HRN mutant was co-expressed with an HR2
mutant, FZO1 activity was not restored (Fig. 2, B and C). Finally, co-
expression of any two GTPase mutants did not restore mitochondrial
fusion.
The simplest interpretation of these data is that Fzo1p functions as an
oligomer in whichGTPase and heptad repeat activity can be donated by
different molecules. However, it is also possible that the GTPase and
heptad repeat regions act independently (for example, sequentially) at
different steps in the fusion pathway. We sought to distinguish these
possibilities by testing directly for Fzo1p oligomerization.
Fzo1p Functions as an Oligomer—We sought evidence for Fzo1p oli-
gomerization by using a co-immunoprecipitation assay. In these exper-
iments, HA-Fzo1p and Myc-Fzo1p were co-expressed at endogenous
levels in fzo1 cells.WhenMyc-Fzo1p was immunoprecipitated,10%
of HA-Fzo1p co-immunoprecipitated (Fig. 3, lane 3). Similarly, the
mammalian orthologs Mfn1 and Mfn2 have previously been shown to
form homotypic and heterotypic complexes (4). Taken in conjunction
with our intragenic complementation results, these interaction data
strongly suggest that Fzo1p functions as an oligomer during mitochon-
drial fusion.
If intragenic complementation is due to oligomerization between
mutant Fzo1p molecules, we would expect complementing mutant3 E. Griffin and D. Chan, unpublished results.
FIGURE 3. Self-association of Fzo1p. Lysates (labeled “Lysate”) from yeast expressing
the indicated HA-Fzo1p andMyc-Fzo1p alleles were immunoprecipitated with anti-Myc
antibodies (labeled “Myc IP”) and analyzed byWestern blottingwith anti-Myc (9E10) and
anti-HA (12CA5) antibodies. The immunoprecipitate samples are loaded at 10 equiva-
lents of the lysate samples.
TABLE 1
Summary of intragenic complementation data presented in Fig. 2
For simplicity, each data point is presented twice. “” indicates growth on glycerol
plates and tubular mitochondrial morphology. “” indicates failure to grow on
glycerol plates and fragmented mitochondrial morphology.
K200A S201N T221A V172P L501A,504A L819P
K200A     
S201N     
T221A     
V172P     
L501A,504A     
L819P     
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pairs to co-immunoprecipitate. Indeed, the Fzo1p GTPase mutants
fzo1(T221A) and fzo1(K200A) interacted with each of the heptad repeat
mutants fzo1(V172P), fzo1(L501A, L504A), and fzo1(L819P) (Fig. 3,
lanes 4–6 and 10–12). In contrast, fzo1(S201N) interacted weakly with
all the heptad repeat mutants (Fig. 3, lanes 7–9) and was unable to
complement (Table 1 and Fig. 2), suggesting efficient oligomerization is
necessary for intragenic complementation.
Surprisingly, all of our null mutants retained the ability to form
homotypic interactions. Mutations in HRN, HR1, HR2, or in both HR1
and HR2 had little effect on Fzo1p self-assembly (Fig. 4, lanes 7–10).
More of an effect was seen with the GTPase mutants, most notably
S201N, which displayed the lowest levels of interaction (Fig. 4, lanes
4–6). Given that mutations in no single domain completely disrupt
Fzo1p interactions, we conclude that oligomerization of Fzo1p likely
involves interactions between multiple domains, and that the null phe-
notypes of the heptad repeat and GTPase mutants are not a result of
Fzo1p dissociation.
Interaction between Fzo1p-HRN/GTPase and Fzo1p-HR1/HR2—Be-
cause several domains likely work in concert to stabilize full-length
Fzo1p oligomerization, we attempted to develop a simplified system for
examining domain interactions.We tested whether fragments of Fzo1p
could physically interact with each other. We analyzed an N-terminal
Fzo1p fragment containing HRN and the GTPase domain (Fzo1p-
HRN/GTPase, residues 1–415) and a C-terminal fragment that
includes HR1, the TM and HR2 (Fzo1p-HR1/HR2, residues 416–855).
Fzo1p-HR1/HR2, like full-length Fzo1p, interacted efficiently with full-
length Fzo1p (Fig. 5, lanes 3 and 10). A weaker interaction was also seen
between two Fzo1p-HR1/HR2 fragments (Fig. 5, lane 11). Most inter-
estingly, the non-overlapping Fzo1p-HRN/GTPase and Fzo1p-HR1/
HR2 fragments interacted with each other as efficiently as the full-
length Fzo1p-Fzo1p interaction (Fig. 5, lane 12). Thus, Fzo1p-HR1/HR2
has at least twomodes of interaction: a homotypic interactionwith itself
and a heterotypic interaction with Fzo1p-HRN/GTPase.
We confirmed the interaction between Fzo1p-HRN/GTPase and
Fzo1p-HR1/HR2 by showing that Fzo1p-HR1/HR2 can recruit Fzo1p-
HRN/GTPase to mitochondria. Full-length Myc-Fzo1p (n  200, Fig. 5,
B–D) and Fzo1p-HR1/HR2 (data not shown) displayed a uniform mito-
chondrial localization pattern in all cells. In contrast, Myc-Fzo1p-HRN/
FIGURE 4. Fzo1p null mutants form homotypic oligomers. Co-immunoprecipitations
were performed as in Fig. 3. Yeast strains containedMyc- andHA-tagged alleles of Fzo1p
as indicated. HRN, V172P; HR1, L501A,L504A; HR2, L819P; HR1/2, L501A,L504A,L819P.
FIGURE 5. Two interacting fragments of Fzo1p. A, co-immunoprecipitations were
performed as in Fig. 3. Fzo1p-HRN/GTPase (residues 1–415) is referred to as ‘N ’ and
Fzo1p-HR1/HR2 (residues 416–855) is referred to as ‘C’. wt: full-length Fzo1p. B–J,
immunofluorescence (red, middle panels) was used to localize Myc-tagged full-
length Fzo1p (Myc-Fzo1p, B–D), Myc-Fzo1p-HRN/GTPase (E–G), and Myc-Fzo1p-
HRN/GTPase when co-expressed with HA-Fzo1p-HR1/HR2 (H–J) in fzo1 cells. Mito-
chondria were labeled with mito-GFP (left panels). Overlays of the two signals are
shown in the merged images (right panels). Bar, 1 m.
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GTPase localization was non-mitochondrial and probably cytosolic in all
cells (n200, Fig. 5,E–G).However, co-expressionwith themitochondrial
HA-Fzo1p-HR1/HR2 caused redistribution of Myc-Fzo1p-HRN/GTPase
to mitochondria in 41% (7% completely mitochondrial, 34.5% mitochon-
drial and cytosolic) of cells (n 200, Fig. 5, H–J). These data confirm the
physical interaction between Fzo1p-HRN/GTPase and Fzo1p-HR1/HR2
and indicate that this interaction occurs onmitochondria.
Having identified an interaction between these two Fzo1p fragments,
we tested whether this interaction is functionally important. The null
mutations identified previously were tested for their effect on the bind-
ing of Fzo1p-HRN/GTPase to Fzo1p-HR1/HR2. When mutations in
either HR1 or HR2 were introduced into Fzo1p-HR1/HR2, its interac-
tion with Fzo1p-HRN/GTPase was completely abolished (Fig. 6, lanes
11–13). Similarly, whenmutations in HRN or the GTPase domain were
introduced into Fzo1p-HRN/GTPase, its interaction with Fzo1p-HR1/
HR2 was abolished (Fig. 6, lanes 7–10). Therefore, our null alleles indi-
cate that the interaction of Fzo1p-HRN/GTPase with Fzo1p-HR1/HR2
is essential for fusion.
Functional Complementation between Fzo1p-HRN/GTPase and
Fzo1p-HR1/HR2—Given their physical interaction on mitochondria,
we tested if co-expression of Fzo1p-HRN/GTPase and Fzo1p-HR1/
HR2 could restore mitochondrial fusion. When expressed individually,
neither fragment supported growth on glycerol or rescued mitochon-
drial morphology (Fig. 7, A and B). Remarkably, the co-expression of
Fzo1p-HRN/GTPase and Fzo1p-HR1/HR2 was sufficient to restore
fusion. These cells grew robustly on glycerol plates and displayed largely
tubular mitochondria (Fig. 7, A and B). Moreover, cells co-expressing
the Fzo1p fragments show significant mitochondrial fusion in the
zygotic fusion assay (Table 2) (28). These data indicate that Fzo1p-
HRN/GTPase and Fzo1p-HR1/HR2 form a complex competent to sup-
port mitochondrial fusion.
DISCUSSION
In this study, we show that Fzo1p functions as an oligomer during
mitochondrial fusion. In support of this conclusion, Fzo1p forms homo-
typic oligomers detectable by co-immunoprecipitation. In addition,
specific pairs of fzo1 null alleles are capable of intragenic complemen-
tation. Intragenic complementation can occur between pairs ofmutants
if each mutant affects a different domain of an oligomerized multido-
main protein. Within the oligomer, different functional domains are
donated from distinct molecules, resulting in the restoration of activ-
ity (27). An alternative scenario for intragenic complementation is
that the GTPase and heptad repeat domains are not required on the
same molecule, because they act at different steps in the fusion reac-
tion. Although we cannot formally exclude this latter explanation,
the observation that Fzo1p molecules physically associate strongly
favors the former model.
Our intragenic complementation data provide insight into the
requirements for the activity of different domains on Fzo1p molecules
FIGURE 6. The GTPase and heptad repeat regions are required for the interaction
between Fzo1p-HRN/GTPase and Fzo1p-HR1/HR2. Co-immunoprecipitations were
performedand labeledas inFig. 3. The indicatedmutationswerepresent ineither Fzo1p-
HRN/GTPase (HRN, V172P, K200A, S201N, and T221A) or HA-Fzo1p-HR1/HR2 (HR1:
L501A,L504A; HR2: L819P). FL: full-length wild-type Fzo1p.
FIGURE 7.Co-expressionof the Fzo1p-HRN/GTPase andFzo1p-HR1/HR2 fragments of Fzo1p complements fzo1.A, serial dilution assay for growth onglycerolwas performed
as described in Fig. 1. B, percentage of cells displaying the indicated mitochondrial morphologies during log phase growth in selective minimal dextrose media (images of the
morphological classes are provided in Fig. 1). 200 live cells were counted for each strain.
TABLE 2
Strains used in this study
Yeast expressing mito-GFP and mito-DsRed were mated in YPD for 5 h. Following
fixation, 200 large-budded zygotes were scored for mitochondrial fusion.
Strains mated Mitochondrialfusion
%
FZO1 dnm1 x FZO1 dnm1 96
fzo1 dnm1 x fzo1 dnm1 0
fzo1 dnm1  pRS414-9XMYC-FZO1 x fzo1 dnm1 
pRS414-9XMYC-FZO1
86
fzo1 dnm1  pRS414-9XMYC-FZO1(HRN/GTPase)
pRS416-6XHA-FZO1(HR1/HR2) x fzo1 dnm1 
pRS414-9XMYC-FZO1(HRN/GTPase)
pRS416-6XHA-FZO1(HR1/HR2)
38.5
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within these oligomers. Within an Fzo1p oligomer, one molecule must
possess the activity of all three heptad repeats (for example, a GTPase
mutant). A second molecule must possess GTPase activity but not nec-
essarily full heptad repeat activity (for example, an HRN, HR1, or HR2
mutant). Thus co-expression of Fzo1p molecules with heptad repeat
activity and Fzo1p molecules with GTPase activity restores fusion,
whereas co-expression of two heptad repeat mutants or two GTPase
mutants does not restore fusion. Because Fzo1p is required on adjacent
mitochondria to support fusion (29), an interesting question that
remains to be addressed is whether the intragenic complementation we
observe occurs in cis (in a complex formed on onemitochondrion) or in
trans (in a complex that spans two mitochondria prior to fusion). In
principle, this issue could be determined using an in vitro fusion assay,
but unfortunately the available assay does not work for mitochondria
isolated from yeast that are incompetent for respiration (29).
We have also identified binding of Fzo1p-HRN/GTPase to Fzo1p-
HR1/HR2 as an interaction critical for mitochondrial fusion. First, co-
expression of Fzo1p-HRN/GTPase and Fzo1p-HR1/HR2 supports
mitochondrial fusion. Second, these Fzo1p fragments physically inter-
act with each other. Finally, mutations in the GTPase domain or heptad
repeat regions block this interaction and cause complete loss of mito-
chondrial fusion activity.
Future work will help to resolve the complex interactions occurring
between Fzo1p molecules. Fzo1p is a large membrane-associated
GTPase with some similarities to the dynamin family ofmechanochem-
ical membrane-severing enzymes. Dynamins are characterized by their
oligomerization-dependent stimulation of GTP hydrolysis. Thus, it will
be interesting to test the possibility that intermolecular interactions
within an Fzo1p oligomer regulate its GTPase activity. Given that co-
expression of a functional GTPase domain on one Fzo1p molecule and
functional heptad repeat regions on another molecule is sufficient to
support fusion, it is possible that the heptad repeats could play a role in
regulating GTPase activity. For example, based on its location near the
C terminus, it has been suggested HR2 could function analogously to
the GTPase effector domain of dynamin (21). In vitro characterization
of recombinant Fzo1p fragments can be used to address this possibility.
Ultimately, structural information will be required to fully understand
the nature of the Fzo1p oligomer.
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